neurodegenerative diseases

brain pills alzheimers drug reaction down syndrome
Biotech

Cognition's phase 2 SHIMMER results allow dementia drug to shine

The phase 2 study in dementia with Lewy bodies met its primary endpoint of safety and tolerability, Cognition said.
James Waldron Dec 18, 2024 7:00am
psych neuro brain

GSK pays Flagship biotech $80M for preclinical neuro pact

Nov 12, 2024 6:30am
Vertical blocks spelling out TMS sitting next to a brain

Brain stimulation slows Alzheimer's disease in one-year trial

Oct 31, 2024 6:45am
dart board miss failure

GemVax's peptide drug fails phase 2a neurodegenerative trial

Oct 29, 2024 11:28am
rocket launch satellite space fly blast off

Booster takes off with protein degraders for neurodegeneration

Oct 10, 2024 9:25am
Cutting a rope knot

Potential new Alzheimer's drugs target tangles of tau

Sep 19, 2024 2:42pm